Anticholinergics Tied to Physical Performance Decline in Older Adults
By Lori Solomon HealthDay Reporter
WEDNESDAY, July 16, 2025 -- Anticholinergics are associated with physical performance decline in older adults, according to a study published online July 10 in JAMA Network Open.
Shelly L. Gray, Pharm.D., from the University of Washington in Seattle, and colleagues assessed whether anticholinergic exposure is associated with accelerated physical performance decline in older adults. The analysis included 4,283 participants aged 65 years and older in the Adult Changes in Thought study at Kaiser Permanente Washington (February 1994 to March 2020).
The researchers found that compared with nonusers, there was a greater decline rate in gait speed among those with a 10-year total standardized daily dose (SDD) ≥1,096 (mean difference [MD] per year, −0.0132 m/s) and for two-year mean SDD ≥0.5 (MD per year, −0.0101 m/s). The lowest quasi-information criterion was seen for the four-year weighted cumulative exposures model, which showed a significantly greater decline rate per one-unit increase in weighted mean SDD (MD per year, −0.0034 m/s). For grip strength, there were no significant associations between conventional exposures, but the six-year weighted cumulative exposures model had the lowest quasi-information criterion (MD per year, −0.0329 kg).
"Anticholinergics are associated with numerous adverse outcomes in older adults; therefore, it is essential for clinicians to avoid their use when possible, prescribe the lowest effective dose, and periodically reevaluate patients to identify deprescribing opportunities to minimize potential harms," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted July 2025
Read this next
Broader Formulary Coverage Linked to Lower Odds of MS Relapse
FRIDAY, Aug. 8, 2025 -- Broader formulary coverage is associated with lower odds of multiple sclerosis (MS) relapse among Medicare beneficiaries, according to a study published...
'Heart Age' Often Older Than Chronological Age
FRIDAY, Aug. 8, 2025 -- The Predicting Risk of Cardiovascular Disease Events (PREVENT) equation risk age is older than chronological age on average, with greater discordance for...
Nonlinear Inverse Association Seen for Step Count, Peak Cadence With MACE
THURSDAY, Aug. 7, 2025 -- There are nonlinear, inverse associations for step count and peak cadence with the risk for major adverse cardiovascular events (MACE) among individuals...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.